Ligand Pharmaceuticals, Inc. (LGND)
285.21
+1.11
(+0.39%)
USD |
NASDAQ |
Sep 01, 11:16
Ligand Pharmaceuticals Free Cash Flow : 119.83M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 119.83M |
| March 31, 2026 | 114.06M |
| December 31, 2025 | 38.04M |
| September 30, 2025 | 20.43M |
| June 30, 2025 | 37.75M |
| March 31, 2025 | 33.29M |
| December 31, 2024 | 76.98M |
| September 30, 2024 | 5.711M |
| June 30, 2024 | -9.209M |
| March 31, 2024 | -20.61M |
| December 31, 2023 | -5.221M |
| September 30, 2023 | 89.75M |
| June 30, 2023 | 98.75M |
| March 31, 2023 | 104.32M |
| December 31, 2022 | 119.93M |
| September 30, 2022 | 94.03M |
| June 30, 2022 | 96.13M |
| March 31, 2022 | 106.42M |
| December 31, 2021 | 70.04M |
| September 30, 2021 | 40.67M |
| June 30, 2021 | 35.16M |
| March 31, 2021 | 43.96M |
| December 31, 2020 | 50.13M |
| September 30, 2020 | 46.71M |
| June 30, 2020 | 27.77M |
| Date | Value |
|---|---|
| March 31, 2020 | -57.67M |
| December 31, 2019 | -29.34M |
| September 30, 2019 | 9.688M |
| June 30, 2019 | 43.85M |
| March 31, 2019 | 178.56M |
| December 31, 2018 | 194.06M |
| September 30, 2018 | 197.80M |
| June 30, 2018 | 198.36M |
| March 31, 2018 | 127.82M |
| December 31, 2017 | 91.19M |
| September 30, 2017 | 77.97M |
| June 30, 2017 | 68.09M |
| March 31, 2017 | 54.72M |
| December 31, 2016 | 43.46M |
| September 30, 2016 | 35.53M |
| June 30, 2016 | 28.21M |
| March 31, 2016 | 46.34M |
| December 31, 2015 | 40.37M |
| September 30, 2015 | 36.61M |
| June 30, 2015 | 29.91M |
| March 31, 2015 | 24.91M |
| December 31, 2014 | 20.57M |
| September 30, 2014 | 22.35M |
| June 30, 2014 | 18.26M |
| March 31, 2014 | 17.27M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 22.61B |
| Eli Lilly & Co. | 13.56B |
| Merck & Co., Inc. | 16.06B |
| Zevra Therapeutics, Inc. | 32.62M |
| Liquidia Corp. | 150.69M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 24.02M |
| Cash from Investing (Quarterly) | 321.12M |
| Cash from Financing (Quarterly) | 546.43M |
| Free Cash Flow Per Share (Quarterly) | 0.9778 |
| Free Cash Flow to Equity (Quarterly) | -658.12M |
| Free Cash Flow to Firm (Quarterly) | 22.67M |
| Free Cash Flow Yield | 2.01% |